Emergency Medicine’s #1 Journal Publication: Clinical advances and trends from the most trusted emergency medical news source in emergency medicine.
Emergency Medicine News - Current Procalcitonin Utilization and Publications
Claim This Podcastby Emergency Medicine News
5.0(2 reviews)
7 episodes
Updated Inactive
Accepts GuestsHas SponsorsLocation 🇺🇸
Podcast Overview
Emergency Medicine’s #1 Journal Publication: Clinical advances and trends from the most trusted emergency medical news source in emergency medicine.
Language
🇺🇲
Publishing Since
3/27/2020
1 verified contact email on file for Emergency Medicine News - Current Procalcitonin Utilization and Publications
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
November 19, 2021
Episode 7: The Power of PCR and PCT Testing for Severe Acute Respiratory Infections in the Emergency Department
<strong>David F. Gaieski, MD</strong>, Associate Professor, Emergency Medicine, Jefferson University Hospitals, Philadelphia, interviews <strong>Daniel Feinstein, MD, FACP, ACRP-PI</strong>, Medical Director, Critical Care, Novant Health, about the outcomes and benefits associated with the use of syndromic PCR testing and procalcitonin in the emergency department for patients with suspected and confirmed respiratory infections such as community-acquired pneumonia and COVID-19.<br><br> Opinions expressed in this podcast are not necessarily those of bioMérieux, Inc.<br><br>
September 9, 2021
Episode 6: New Risk Model in the ED
David F. Gaieski, MD, Associate Professor, Emergency Medicine, Jefferson University Hospitals, Philadelphia, interviews Charles B. Cairns, MD, the Walter H. and Leonore Annenberg Dean of the College of Medicine, Senior Vice President for Medical Affairs, and Professor of Medicine and Emergency Medicine at Drexel University, about the new potential for care utilizing host response biomarkers, pathogen identification and surveillance as well as newly published research.<br><br> Opinions expressed in this podcast are not necessarily those of bioMérieux, Inc
July 21, 2021
Episode 5: The Advantages of Using Procalcitonin and CLARION™ for Emergency Physicians
<p><strong>David F. Gaieski, MD</strong>, Associate Professor, Emergency Medicine, Jefferson University Hospitals, Philadelphia, interviews <strong>Michael R. Broyles, BSPharm, RPh, PD, PharmD, </strong>Director of Clinical Pharmacy and Laboratory Services, Five Rivers Medical Center, Arkansas, about the advantages of using procalcitonin and data analytics for emergency physicians.</p> <p>Opinions expressed in this podcast are not necessarily those of bioMérieux, Inc.</p>
7 total episodes available
Deep-dive analytics for Emergency Medicine News - Current Procalcitonin Utilization and Publications
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Emergency Medicine News - Current Procalcitonin Utilization and Publications?
- How often does this podcast release new episodes?
This podcast updates inactive.
- Where can I listen to this podcast?
This podcast is available on 7 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.